Modelling metabolic diseases and drug response using stem cells and organoids

Area of Science:

• Biomedical research
• Regenerative medicine
• Disease modeling

Background:

• Metabolic diseases (obesity, diabetes, cardiovascular disease) pose significant global health risks.
• Understanding disease mechanisms is hindered by limitations in current human model systems.
• Advances in stem cell and organoid technologies offer promising new avenues for research.

Purpose of the Study:

• To review the progress in using stem cell-derived metabolic cell types and organoids for metabolic disease research over the past decade.
• To highlight the advantages of human stem cells and organoids over traditional animal models.
• To discuss the potential applications in drug discovery and personalized medicine for metabolic diseases.

Main Methods:

• Review of scientific literature on stem cell and organoid generation and application in metabolic disease research.
• Analysis of the capabilities of stem cell-derived models in replicating human organ physiology.
• Discussion of gene editing tools and functional genomics in conjunction with organoid technology.

Main Results:

• Stem cell and organoid technologies enable the creation of human-specific models for metabolic diseases.
• These models replicate histological, molecular, and physiological properties of human organs.
• Significant progress has been made in applying these models to study obesity and liver diseases.

Conclusions:

• Stem cell-derived organoids, combined with gene editing, represent a revolutionary approach to metabolic disease research.
• These systems facilitate understanding drug mechanisms, efficacy, and toxicity.
• The potential for personalized therapies and accelerated drug screening is greatly enhanced.